News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,330 Results
Type
Article (87520)
Company Profile (807)
Press Release (773981)
Multimedia
Podcasts (177)
Webinars (28)
Section
Business (233090)
Career Advice (4140)
Deals (39809)
Drug Delivery (140)
Drug Development (91278)
Employer Resources (203)
FDA (18296)
Job Trends (17406)
News (397476)
Policy (39928)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (128)
Alliances (56980)
ALS (147)
Alzheimer's disease (1689)
Antibody-drug conjugate (ADC) (262)
Approvals (18329)
Artificial intelligence (509)
Autoimmune disease (98)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (520)
Cancer (4113)
Cardiovascular disease (357)
Career advice (3562)
Career pathing (38)
CAR-T (252)
CDC (57)
Cell therapy (703)
Cervical cancer (33)
Clinical research (75738)
Collaboration (1436)
Company closure (4)
Compensation (949)
Complete response letters (62)
COVID-19 (2962)
CRISPR (84)
C-suite (613)
Cystic fibrosis (140)
Data (4796)
Decentralized trials (2)
Denatured (64)
Depression (113)
Diabetes (461)
Diagnostics (7102)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (242)
Drug pricing (195)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (99097)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133313)
Executive appointments (998)
FDA (20863)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1295)
Gene editing (178)
Generative AI (52)
Gene therapy (561)
GLP-1 (1033)
Government (5391)
Grass and pollen (8)
Guidances (372)
Healthcare (20938)
HIV (49)
Huntington's disease (41)
IgA nephropathy (64)
Immunology and inflammation (255)
Immuno-oncology (22)
Indications (58)
Infectious disease (3212)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (197)
Interviews (816)
IPO (17931)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (37)
Legal (10150)
Liver cancer (92)
Longevity (13)
Lung cancer (591)
Lymphoma (271)
Machine learning (32)
Management (66)
Manufacturing (667)
MASH (145)
Medical device (14904)
Medtech (14930)
Mergers & acquisitions (22777)
Metabolic disorders (1180)
Multiple sclerosis (140)
NASH (23)
Neurodegenerative disease (236)
Neuropsychiatric disorders (63)
Neuroscience (2754)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (60)
Obesity (569)
Opinion (315)
Ovarian cancer (140)
Pain (172)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (32)
Patents (428)
Patient recruitment (334)
Peanut (57)
People (66337)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23358)
Phase II (32860)
Phase III (24789)
Pipeline (2823)
Policy (301)
Postmarket research (3554)
Preclinical (10541)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (698)
Real estate (7422)
Recruiting (79)
Regulatory (28112)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (160)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (111)
Vaccines (1060)
Venture capital (68)
Weight loss (403)
Women's health (60)
Worklife (21)
Date
Today (71)
Last 7 days (728)
Last 30 days (2821)
Last 365 days (33441)
2025 (27866)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1282)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51059)
Australia (8976)
California (9753)
Canada (2918)
China (942)
Colorado (411)
Connecticut (432)
Delaware (279)
Europe (117318)
Florida (1437)
Georgia (322)
Hawaii (3)
Idaho (67)
Illinois (826)
India (55)
Indiana (481)
Iowa (20)
Japan (336)
Kansas (127)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1307)
Massachusetts (7295)
Michigan (318)
Minnesota (578)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2709)
New Mexico (32)
New York (2640)
North Carolina (1430)
North Dakota (10)
Northern California (4464)
Ohio (308)
Oklahoma (22)
Oregon (51)
Pennsylvania (2023)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (51)
South Dakota (1)
Southern California (3720)
Tennessee (152)
Texas (1534)
United States (35923)
Utah (294)
Virginia (253)
Washington D.C. (84)
Washington State (836)
West Virginia (4)
Wisconsin (101)
Wyoming (2)
There are 862,330 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Exact Sciences Announces Third Quarter 2025 Results
November 3, 2025
·
19 min read
Press Releases
Mirum Pharmaceuticals to Participate in Upcoming November 2025 Investor Conferences
November 3, 2025
·
2 min read
Press Releases
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 3, 2025
·
19 min read
Press Releases
Savara Announces Participation in Upcoming Investor Healthcare Conferences
November 3, 2025
·
1 min read
Press Releases
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
November 3, 2025
·
19 min read
Press Releases
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
November 3, 2025
·
6 min read
FDA
UPDATE: Tidmarsh Waffles on Resignation, Will Fight To Clear Name
Less than 24 hours after resigning his post as the FDA’s head drug regulator, George Tidmarsh is reportedly reconsidering his decision and vowing to fight for his name and credibility amid a probe into his “personal conduct” at the agency.
November 3, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds
November 3, 2025
·
7 min read
Immunology and inflammation
Neurocrine Goes to China To Grow Pipeline in up to $881M TransThera Deal
At the center of the licensing deal is an NLRP3 inhibitor that has shown “encouraging efficacy in acute inflammation models,” according to TransThera, indicating its potential in various metabolic and inflammatory diseases.
November 3, 2025
·
1 min read
·
Dan Samorodnitsky
Layoff Tracker
Sensei Plans to Cut Workforce While Considering Strategic Alternatives
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
November 3, 2025
·
77 min read
·
BioSpace Editorial Staff
1 of 86,233
Next
